Trabectedin
Spécifications
114899-77-3Numéro CAS
695-026-8Numéro CE
[(1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline]-22-yl] aNom IUPAC
C39H43N3O11SFormule chimique
761.8 g/molMasse molaire
Trabectedin; 114899-77-3; Yondelis; Ecteinascidin; ecteinascidin 743; ET-743; ET743; Et 743; Ect 743; DTXSID2046880; trabectedine; Trabectedina; ID0YZQ2TCP; Ecteinascidins trabectedin; NSC-648766; DTXCID0026880; CHEBI:84050; [(1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline]-22-yl] acetate; Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6R-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20R*))-; (1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1^{3,11}.0^{2,13}.0^{4,9}.0^{15,23}.0^{16,20}]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate; trabectedinum; NSC648766; ((1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro(17,19,28-trioxa-24-thia-13,30-diazaheptacyclo(12.9.6.13,11.02,13.04,9.015,23.016,20)triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline)-22-yl) acetate; (1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro(heptacyclo(12.9.6.1^(3,11).0^(2,13).0^(4,9).0^(15,23).0^(16,20))triacontane-26,1'-isoquinoline)-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate; RefChem:56743; L01CX01; ((1R,2R,3R,11S,12S,14R,26S)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro(17,19,28-trioxa-24-thia-13,30-diazaheptacyclo(12.9.6.13,11.02,13.04,9.015,23.016,20)triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline)-22-yl) acetate; Trabectedin [INN]; Ecteinascidine 743; Ecteinascidin-743; CAS-114899-77-3; UNII-ID0YZQ2TCP; NSC 648766; NSC 684766; Trabectedin [USAN:INN:BAN]; CCRIS 8133; PKVRCIRHQMSYJX-AIFWHQITSA-N; NCGC00181159-01; NCGC00181159-02; (1'R,6R,6aR,7R,13S,14S,16R)-5-(Acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethylspiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinolin]-19-one; Ecteinascidin 743; Et 743; NSC 648766; Yondelis;; TRABECTEDIN [JAN]; TRABECTEDIN [USAN]; TRABECTEDIN [MART.]; TRABECTEDIN [WHO-DD]; Ecteinascidin 743;ET-743; TRABECTEDIN [EMA EPAR]; CHEMBL450449; GTPL2774; orb1307653; SCHEMBL29366408; SCHEMBL29376642; TRABECTEDIN [ORANGE BOOK]; EX-A4317; Tox21_112762; Tox21_113236; EBC-27453; NSC813783; AKOS025401985; CS-1608; DB05109; ECTEINASCIDINS TRABECTEDIN [MI]; FT28354; NSC-684766; NSC-813783; NCGC00181159-04; (1'R,6R,6aR,7R,13S,14S,16R)-6',8,14-Trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro(6,16-(epithiopropanooxymethano)-7,13-imino-6aH-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-5-yl acetate; AC-27767; BP-41453; HY-50936; MS-31361; Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (1'R,6R,6aR,7R,13S,14S,16R)-; F81329; T17155; EN300-19768451; Q2637746; (1'R,6R,6aR,7R,13S,14S,16R)-5-(Acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-spiro[ 6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinolin]-19; (1'R,6R,6aR,7R,13S,14S,16R)-5-(Acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethylspiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinolin]-19-one; (1'R,6R,6aR,7R,13S,14S,16R)-6',8,14-Trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2H,2'H,6aH-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetate; (6R,6aR,7R,13S,14S,16R,20R)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'H,6aH-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetateSynonymes
Produits contenant Trabectedin
욘델리스주사1.0밀리그램(트라벡테딘)ヨンデリス点滴静注用0.25mg/ヨンデリス点滴静注用1mgYONDELIS 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONYONDELIS 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONYONDELIS 1 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONYONDELIS 0,25 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONTRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTRABECTEDINA SUN 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFGTRABECTEDINA EVER PHARMA 1 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFGTRABECTEDINA EVER PHARMA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Page 1 sur 4
Entreprises vendant Trabectedin
ML
MSN LaboratoriesIndiaEV
EVER VALINJECTAustriaCS
Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaBB
BrightGene Bio-Medical Technology Co.,Ltd.ChinaSS
Shenzhen Sijia Pharmaceutical Co., Ltd.ChinaJH
Jiangsu Hengrui Pharmaceutical Co., Ltd.ChinaWP
Wisdom Pharmaceutical Co.,Ltd.ChinaJ&
Johnson & Johnson Innovative MedicineUnited StatesPage 1 sur 3